CFDE Data Portal | Search EPHX3

	Label	Description
	EPHX3 associations Collection (Entity type)	Associations for EPHX3_associations
	EPHX3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EPHX3 Gene (Entity type)	ENSG00000105131 - epoxide hydrolase 3
	GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 5 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 11 V 9 CRIZOTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 7 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 11 V 6 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

EPHX3 associations

Associations for EPHX3_associations

EPHX3 associations.tsv

A file from IDG as part of the Harmonizome project

EPHX3

ENSG00000105131 - epoxide hydrolase 3

GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP

A Gene Set from LINCS

GSE239844 6 V 5 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

GSE239844 11 V 9 CRIZOTINIB HUMAN UP

A Gene Set from LINCS

GSE216043 cisplatin 7 v 0 human dn

A Gene Set from LINCS

GSE143782 calcitriol 7 v 11 human dn

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn

A Gene Set from LINCS

GSE216043 11 V 6 CISPLATIN HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.